Advertisement

Introduction

Role of Estrogens in Liver Carcinogenesis
  • James D. Yager
  • Joanne Zurlo

Abstract

In women, while inappropriate and/or excessive exposure to estrogens is generally associated with breast, endometrial, and vaginal cancer, an increased risk for developing hepatic neoplasms also represents a public health issue. One of the first reports of this association was by Baum, et al. (1), who in 1973 reported an increased incidence of liver neoplasms in women with a history of long-term use of oral contraceptives (OC). Since then, there have been numerous reports confirming an association between OC use and the development of hepatocellular adenomas and carcinomas (2, 3). A recent report of a case-control study in Milan presents data showing that the increased relative risk was directly related to duration of use and, interestingly, persisted for longer than 10 years after exposure ended (4).

Keywords

Syrian Hamster Redox Cycling Ethinyl Estradiol Liver Carcinogenesis Liver Growth 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baum JK, Holtz F, Bookstein JJ, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 2:926–929.PubMedCrossRefGoogle Scholar
  2. 2.
    Li JJ, Kirkman H, Li SA (1992) Synthetic estrogens and liver cancer: Risk analysis of animal and human data. In Li JJ, Nandi S, Li SA (eds): Hormonal Carcinogenesis. New York: Springer-Verlag, pp 217–224.Google Scholar
  3. 3.
    Palmer JR, Rosenberg L, Kaufman D, et al. (1989) Oral contraceptive use and liver cancer. Am J Epidemiol 130: 878–882.PubMedGoogle Scholar
  4. 4.
    Tavanti A, Negri E, Parazzini F, et al. (1993) Female hormone utilisation and risk of hepatocellular carcinoma. Brit J Cancer 67:636–637.Google Scholar
  5. 5.
    Taper HS (1978) The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats. Cancer 42:462–467.PubMedCrossRefGoogle Scholar
  6. 6.
    Yager JD Jr, Yager R (1980) Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40:3680–3685.PubMedGoogle Scholar
  7. 7.
    Cameron R, Imaida K, Ito N (1981) Promotive effects of ethinyl estradiol in hepatocarcinogenesis initiated by diethylnitrosamine in male rats. Gann 72:339–340.PubMedGoogle Scholar
  8. 8.
    Wanless IR, Medline A (1982) Role of estrogens as promoters of hepatic neoplasia. Lab Invest 46:313–320.PubMedGoogle Scholar
  9. 9.
    Yager JD, Zurlo J, Ni N (1991) Sex hormones and tumor promotion in liver. Proc Soc Exptl Biol Med 198:667–674.Google Scholar
  10. 10.
    Coe JE, Ishak KG, Ross MJ (1990) Estrogen induction of hepatocellular carcinomas in Armenian hamsters. Hepatology 11:570–577PubMedCrossRefGoogle Scholar
  11. 11.
    Schulte-Hermann R, Ochs H, Bursch W, Parzefall W (1988) Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Res 48:2462–2468.PubMedGoogle Scholar
  12. 12.
    Vickers AEM, Lucier GW (1991) Estrogen receptor, epidermal growth factor receptor and cellular ploidy in elutriated subpopulations of hepatocytes during liver tumor promotion by 17 µ-ethinylestradiol in rats. Carcinogenesis 12:391–399.PubMedCrossRefGoogle Scholar
  13. 13.
    Mayol X, Neal G.E, Davies R, et al. (1992) Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes. Carcinogenesis 13:2381–2388.PubMedCrossRefGoogle Scholar
  14. 14.
    Peraino C, Fry RJM, Staffeldt E, Christopher JP (1975) Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res 35:2884–2890.PubMedGoogle Scholar
  15. 15.
    Yager JD, Roebuck BD, Paluszcyk TL, Memoli VA (1986) Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis 7:2007–2014.PubMedCrossRefGoogle Scholar
  16. 16.
    Tanaka K, Smith PF, Stromberg PC, et al. (1992) Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol Appl Pharmacol 116:71–77.PubMedCrossRefGoogle Scholar
  17. 17.
    Schulte-Hermann R (1974) Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol 3:97–158.PubMedCrossRefGoogle Scholar
  18. 18.
    Ni N, Yager JD (1994) Co-mitogenic effects of estrogens on DNA synthesis induced by various growth factors in cultured female rat hepatocytes. Hepatology 19:183–192.PubMedCrossRefGoogle Scholar
  19. 19.
    Yager JD, Shi YE (1991) Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis. Preventive Med 20:27–37.CrossRefGoogle Scholar
  20. 20.
    Ni N, Yager JD (1994) The co-mitogenic effects of various estrogens for TGF-µ-induced DNA synthesis in cultured female rat hepatocytes. Cancer Lett, 841:133–140.CrossRefGoogle Scholar
  21. 21.
    Jirtle RL, Meyer SA (1991) Liver tumor promotion: Effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β expression. Digestive Dis Sci 36:659–668.CrossRefGoogle Scholar
  22. 22.
    Barbason H, Rassenfosse C, Betz EH (1983) Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. Brit J Cancer 47:517–525.PubMedCrossRefGoogle Scholar
  23. 23.
    Abanobi SE, Lombardi B, Shinozuka H (1982) Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline-devoid diet and their suppression by phenobarbital. Cancer Res 42:412–415.PubMedGoogle Scholar
  24. 24.
    Yager JD, Zurlo J, Sewall C, et al. (1994) Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. Carcinogenesis 15:2117–2123.PubMedCrossRefGoogle Scholar
  25. 25.
    Farber E (1990) Clonal adaptation during carcinogenesis. Biochem Pharmacol 39:1837–1846.PubMedCrossRefGoogle Scholar
  26. 26.
    Jirtle RL, Hankins GR, Reisenbichler H, Boyer IJ (1994) Regulation of mannose 6-phosphate/insulin-like growth factor-H receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 15:1473–1478.PubMedCrossRefGoogle Scholar
  27. 27.
    Martucci CP, Fishman J (1993) P450 enzymes of estrogen metabolism. Pharmacol Ther 57:237–257.PubMedCrossRefGoogle Scholar
  28. 28.
    Guengerich FP (1991) Oxidation of estrogens and other steroids by cytochrome P-450 enzymes: Relevance to tumorigenesis. In Li JJ, Nandi S, Li SA (eds): Hormonal Carcinogenesis: Proceedings of the first international symposium. New York: Springer-Verlag, pp 104–109.Google Scholar
  29. 29.
    Fishman J, Swaneck G (1991) Differential interactions of estradiol metabolites with the estrogen receptor: Genomic consequences and tumorigenesis In: Li JJ, Nandi S, Li SA (eds) Hormonal Carcinogenesis, New York, Springer-Verlag, pp 95–103.Google Scholar
  30. 30.
    Telang NT, Suto A, Wong G, et al. (1992) Induction by estrogen metabolite 16a-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 84:634–638.PubMedCrossRefGoogle Scholar
  31. 31.
    Liehr JG, Roy D (1990) Free radical generation by redox cycling of estrogens. Free Rad Biol Med 8: 415–423.PubMedCrossRefGoogle Scholar
  32. 32.
    Han X, Liehr JG (1994) DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: Hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 15:997–1000.PubMedCrossRefGoogle Scholar
  33. 33.
    Roy D, Liehr JG (1991) Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: Covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. Cancer Res 51:3883–3885.Google Scholar
  34. 34.
    Malins DC, Holmes EH, Polissar NL, Gunselman SJ (1993) The etiology of breast cancer: Characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 71: 3036–3043.Google Scholar
  35. 35.
    Li Y, Trush MA, Yager JD (1994) DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis 15:1421–1427PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • James D. Yager
  • Joanne Zurlo

There are no affiliations available

Personalised recommendations